Randomized, Placebo‐Controlled Pilot Study of Naproxen During Dental Implant Osseointegration
2025

Effects of Naproxen on Dental Implant Healing

Sample size: 12 publication Evidence: low

Author Information

Author(s): Kumchai Hattanas, Taub Daniel I., Tomlinson Ryan E.

Primary Institution: Thomas Jefferson University

Hypothesis

The use of NSAIDs in the immediate postoperative period would lead to decreased implant stability due to impaired dental implant osseointegration.

Conclusion

This pilot study provides effect sizes and sample size estimates for future studies to determine recommendations regarding NSAID usage following dental implant surgery.

Supporting Evidence

  • Subjects receiving naproxen had a modest increase in ISQ values, while those on placebo had a much larger increase.
  • 55% more marginal bone loss was observed in the naproxen group at 4 weeks compared to the placebo group.
  • 68% of patients with early failed dental implants reported a history of NSAIDs usage after surgery.

Takeaway

This study looked at whether taking naproxen after getting dental implants helps or hurts the healing process. It found that naproxen didn't make a big difference in healing compared to a placebo.

Methodology

Subjects receiving a maxillary dental implant were randomized to take naproxen or placebo for 7 days after surgery, with implant stability assessed at multiple follow-up visits.

Potential Biases

Potential bias due to the small number of subjects and the lack of standardization in implant systems.

Limitations

The study had a small sample size and variability in implant sites, which may affect the results.

Participant Demographics

Subjects were aged 25 to 76 years, with a mix of males and females.

Statistical Information

Statistical Significance

p≥0.05

Digital Object Identifier (DOI)

10.1002/cre2.70065

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication